STIMCARDIO Trademark Application Published for Opposition

ChangeBridge: Trademarks - Medical Services (Class 044)

Published March 26th, 2026

Detected March 27th, 2026

Summary

The USPTO has published the STIMCARDIO trademark application for opposition. The application covers a range of medical services and devices, including wearable biometric measurement devices, AI-powered therapy optimization software, and arrhythmia treatment devices. The publication date is March 26, 2026.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has published the trademark application for "STIMCARDIO" (Application No. TM79420735) for a 30-day opposition period, with the publication date set for March 26, 2026. The application seeks to register the mark for a broad array of goods and services, including health and medical information provision via websites, various medical devices (arrhythmia treatment, neuromodulation, biometric measurement), and downloadable software for personalized therapy, treatment optimization, and biometric data collection, including AI-powered applications.

This publication signifies a step in the trademark registration process, allowing third parties to oppose the registration if they believe it infringes on their existing rights. While this is not a regulatory rule or enforcement action, companies operating in the medical device and health tech sectors should be aware of new trademarks being registered, as they can indicate market entry or expansion by competitors. No immediate compliance actions are required for entities other than potential trademark holders who may wish to oppose this application.

Source document (simplified)

← USPTO Trademark Applications

STIMCARDIO

Published for Opposition TM79420735 Kind: published Mar 26, 2026

Abstract

Providing health information via a website; providing medical information via a website; providing medical information via a website, namely providing medical information on treatment progress and compliance to health professionals; Medical device for the treatment of arrhythmias; medical device for non-invasive personalized neuromodulation treatment; wearable medical device used to measure biometric data for medical, diagnostic and therapeutic purposes; wearable medical device including patient monitoring sensors [measurement apparatus] for medical purposes; Downloadable software for providing personalized therapy and treatment optimization to patients; downloadable software applications for providing personalized therapy and treatment optimization to patients; downloadable software using artificial intelligence [AI] for providing personalized therapy and treatment optimization to patients; downloadable software applications using artificial intelligence [AI] for providing personalized therapy and treatment optimization to patients; downloadable software for the treatment of arrhythmias; downloadable software applications for the treatment of arrhythmias; downloadable software using artificial intelligence [AI] for the treatment of arrhythmias; downloadable software applications using artificial intelligence [AI] for the treatment of arrhythmias; downloadable cloud-based software for the treatment of arrhythmias; downloadable cloud-based software for providing personalized therapy and treatment optimization to patients; downloadable software used to collect medical data from patients; downloadable software used to measure biometric data of patients